# Boehringer Ingelheim RCV GmbH & Co KG - Inspection Records

Source: https://www.keypedia.com/companies/boehringer-ingelheim-rcv-gmbh-co-kg/44a0d48b-1c34-490c-87fe-ccfec769342f

> Inspection records and compliance data for Boehringer Ingelheim RCV GmbH & Co KG in Vienna, None. Access full analysis and detailed observations.

---

## Details

- Name: Boehringer Ingelheim RCV GmbH & Co KG
- FEI Number: 3003433722
- City: Vienna
- State: None
- Country Name: Austria
- Address Line 1: Dr.-Boehringer-Gasse 5-11
- Zip Code: None

## Related Documents

- [FDA Inspection 1258048 - Boehringer Ingelheim RCV GmbH & Co KG - 2024-11-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/16b950bf-59de-4188-9b07-5e884ebdfe91) — source: FDA, date: November 12, 2024
- [FDA Inspection 1258048 - Boehringer Ingelheim RCV GmbH & Co KG - 2024-11-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/5629f2fe-63c9-4137-bda3-e90b8505a984) — classification: No Action Indicated (NAI), source: FDA, date: November 12, 2024
- [483 - Boehringer Ingelheim RCV GmbH & Co KG - 2023-12-05](https://www.keypedia.com/records/483/boehringer-ingelheim-rcv-gmbh-co-kg/b2c87001-02b0-4a52-9fdd-a23b233c00bd) — source: FDA, date: December 5, 2023
- [483 - Boehringer Ingelheim RCV GmbH & Co KG - 2023-12-05](https://www.keypedia.com/records/483/boehringer-ingelheim-rcv-gmbh-co-kg/060b49d8-c11a-4a49-b649-a1e4f4140363) — source: FDA, date: December 5, 2023
- [FDA Inspection 1226783 - Boehringer Ingelheim RCV GmbH & Co KG - 2023-12-05](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/58b1a87d-a90e-4ba5-b7e5-ec998156c23b) — source: FDA, date: December 5, 2023
- [483 - Boehringer Ingelheim RCV GmbH & Co KG - 2023-11-16](https://www.keypedia.com/records/483/boehringer-ingelheim-rcv-gmbh-co-kg/5b8989de-6d3a-451f-907b-7ccb9c53d1bf) — source: FDA, date: November 16, 2023
- [FDA Inspection 1223893 - Boehringer Ingelheim RCV GmbH & Co KG - 2023-11-16](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/5b9ef9a3-8f71-4fda-8534-f0f594c7979e) — source: FDA, date: November 16, 2023
- [FDA Inspection 1210971 - Boehringer Ingelheim RCV GmbH & Co KG - 2023-03-02](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/3cfa7c2f-3876-4a03-8a8f-2b34332d7f2c) — classification: No Action Indicated (NAI), source: FDA, date: March 2, 2023
- [FDA Inspection 1182096 - Boehringer Ingelheim RCV GmbH & Co KG - 2022-09-16](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/39d7534c-cf3e-4996-a6fd-8da44ba47824) — classification: No Action Indicated (NAI), source: FDA, date: September 16, 2022
- [FDA Inspection 1170761 - Boehringer Ingelheim RCV GmbH & Co KG - 2021-01-28](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/ae313532-f368-41d2-b5af-f45e1c117cd7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 28, 2021
- [483 - Boehringer Ingelheim RCV GmbH & Co KG - 2018-11-19](https://www.keypedia.com/records/483/boehringer-ingelheim-rcv-gmbh-co-kg/e25819fd-f705-497d-90d5-9e3e164ead31) — source: FDA, date: November 19, 2018
- [FDA Inspection 905984 - Boehringer Ingelheim RCV GmbH & Co KG - 2014-11-11](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/9dcc752f-9d8e-438a-b6b7-777791c65ca2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2014
- [FDA Inspection 857996 - Boehringer Ingelheim RCV GmbH & Co KG - 2013-11-15](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/31194b02-7c3e-4e6f-9c88-933fc3998d2d) — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2013
- [FDA Inspection 829627 - Boehringer Ingelheim RCV GmbH & Co KG - 2013-04-26](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/ba96d9cf-99ed-4102-b996-2120f3646b40) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 26, 2013

## Related Companies

- [Avantor Inc.](https://www.keypedia.com/companies/avantor-inc/d47a07ba-3a58-4e37-84ec-dd93b3d815db)
- [PCAS Finland Oy](https://www.keypedia.com/companies/pcas-finland-oy/19918537-642f-4d1a-a55b-d8c267e069df)
- [AmbioPharm, Inc](https://www.keypedia.com/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf)
- [Centaur Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/f96f4f92-5b20-4b5d-91d8-5b0dbe430494)
- [Sicor de Mexico S.A. de C.V.](https://www.keypedia.com/companies/sicor-de-mexico-sa-de-cv/006df4f6-5196-4ece-917c-fad73f51a7e3)
- [Novacyl (Thailand) Ltd.](https://www.keypedia.com/companies/novacyl-thailand-ltd/a3ab6219-74d7-42bc-a5b7-c5ad487f81dd)
- [Eli Lilly Kinsale Ltd.](https://www.keypedia.com/companies/eli-lilly-kinsale-ltd/1b83e59e-9251-41db-beec-42a9e7018ed4)
- [GenTrac, Inc.](https://www.keypedia.com/companies/gentrac-inc/6649d47e-f060-44e5-9c19-488234df324f)
- [SAFC, Inc.](https://www.keypedia.com/companies/safc-inc/8b9b439f-c427-4b43-85d2-81ce982736be)
- [MSD International GmbH (Singapore Branch)](https://www.keypedia.com/companies/msd-international-gmbh-singapore-branch/8ac4b93f-053e-4462-be8f-63d2ee5d9a0d)

## Related Officers

- [Ram Sihag, PhD](https://www.keypedia.com/people/ram-sihag-phd/b3c50b77-974f-488a-8f16-19c6f4018e1f)
- [Richard Ledwidge](https://www.keypedia.com/people/richard-ledwidge/aaf4f089-8f7a-4d1f-b2e1-5f2e476a22a9)
- [issuing_officer](https://www.keypedia.com/people/ying-xin-fan/905eacc9-1394-4215-9fbc-61c151c0debe)
- [Nailing Zhang](https://www.keypedia.com/people/nailing-zhang/d3814d08-b799-4de1-b901-1b90da0e0178)
- [FDA_PERSONNEL](https://www.keypedia.com/people/pete-amin/7f032e7a-1dfc-4240-ba8d-2bba5f7e5b6b)
- [Prajakta A. Varadkar](https://www.keypedia.com/people/prajakta-a-varadkar/93c01972-2e91-462e-8c2b-4a6520d3dd3f)